|
|
||||||||||||||||||||||||||||||||||||||
The Top 10 DividendRank'ed Nasdaq 100 ComponentsBy The Online Investor Staff, updated Fri., Apr. 26, 5:21 AM
#9. AstraZeneca Plc (NASDAQ:AZN) — 2.8% YIELDAstraZeneca is a holding company. Through its subsidiaries, Co. is engaged in pharmaceutical business focusing on the research, development, manufacturing and commercialization of prescription medicines. Co. is focused on its therapy areas: Oncology, which provides Tagrisso (osimertinib) for lung cancer; BioPharmaceuticals, which provides Farxiga/ Forxiga (dapagliflozin) for Type-2 diabetes, heart failure with reduced ejection fraction and chronic kidney disease; and Rare Disease, which provides Soliris (eculizumab) for paroxysmal nocturnal haemoglobinuria, atypical haemolytic uraemic syndrome, generalised myasthenia gravis and neuromyelitis optica spectrum disorder.
Open the AZN Page at The Online Investor (in a new window) » |
|